Oxidative stress, amyloid-β peptide, and altered key molecular pathways in the pathogenesis and progression of Alzheimer's disease
DA Butterfield, D Boyd-Kimball - Journal of Alzheimer's …, 2018 - content.iospress.com
Oxidative stress is implicated in the pathogenesis and progression of Alzheimer's disease
(AD) and its earlier stage, amnestic mild cognitive impairment (aMCI). One source of …
(AD) and its earlier stage, amnestic mild cognitive impairment (aMCI). One source of …
[HTML][HTML] Mitochondrial regulation of local supply of energy in neurons
G López-Doménech, JT Kittler - Current Opinion in Neurobiology, 2023 - Elsevier
Brain computation is metabolically expensive and requires the supply of significant amounts
of energy. Mitochondria are highly specialized organelles whose main function is to …
of energy. Mitochondria are highly specialized organelles whose main function is to …
Neurofibrillary tangles in Alzheimer's disease: elucidation of the molecular mechanism by immunohistochemistry and tau protein phospho-proteomics
A Metaxas, SJ Kempf - Neural regeneration research, 2016 - journals.lww.com
As a key contributor to memory storage, the synapse is one of the earliest affected neuronal
components in Alzheimers disease (AD). Under physiological conditions, the synaptic …
components in Alzheimers disease (AD). Under physiological conditions, the synaptic …
Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera
E Nagele, M Han, C DeMarshall, B Belinka, R Nagele - PloS one, 2011 - journals.plos.org
After decades of Alzheimer's disease (AD) research, the development of a definitive
diagnostic test for this disease has remained elusive. The discovery of blood-borne …
diagnostic test for this disease has remained elusive. The discovery of blood-borne …
Extracellular matrix proteomics in schizophrenia and Alzheimer's disease
Brain extracellular matrix (ECM) is a highly organized system that consists of collagens,
noncollagenous proteins, glycoproteins, hyaluronan, and proteoglycans. Recognized …
noncollagenous proteins, glycoproteins, hyaluronan, and proteoglycans. Recognized …
Neurodegeneration and Alzheimer's disease (AD). What can proteomics tell us about the Alzheimer's brain?
G Moya-Alvarado, N Gershoni-Emek, E Perlson… - Molecular & Cellular …, 2016 - ASBMB
Neurodegenerative diseases, such as Alzheimer′ s diseases (AD), are becoming more
prevalent as the population ages. However, the mechanisms that lead to synapse …
prevalent as the population ages. However, the mechanisms that lead to synapse …
Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease
I Ferrer, P Andrés‐Benito, K Ausín, R Pamplona… - Brain …, 2021 - Wiley Online Library
Tau hyperphosphorylation is the first step of neurofibrillary tangle (NFT) formation. In the
present study, samples of the entorhinal cortex (EC) and frontal cortex area 8 (FC) of cases …
present study, samples of the entorhinal cortex (EC) and frontal cortex area 8 (FC) of cases …
Recent advances in quantitative neuroproteomics
GE Craft, A Chen, AC Nairn - Methods, 2013 - Elsevier
The field of proteomics is undergoing rapid development in a number of different areas
including improvements in mass spectrometric platforms, peptide identification algorithms …
including improvements in mass spectrometric platforms, peptide identification algorithms …
Label-free quantitative LC–MS proteomics of Alzheimer's disease and normally aged human brains
VP Andreev, VA Petyuk, HM Brewer… - Journal of proteome …, 2012 - ACS Publications
Quantitative proteomics analysis of cortical samples of 10 Alzheimer's disease (AD) brains
versus 10 normally aged brains was performed by following the accurate mass and time tag …
versus 10 normally aged brains was performed by following the accurate mass and time tag …
Role of post‐translational modifications in Alzheimer's disease
The global burden of Alzheimer's disease (AD) is growing. Valiant efforts to develop clinical
candidates for treatment have continuously met with failure. Currently available palliative …
candidates for treatment have continuously met with failure. Currently available palliative …